Skip to content
2000
Volume 11, Issue 1
  • ISSN: 2667-3371
  • E-ISSN: 2667-338X

Abstract

Due to its ability to track drug interactions and their physiological effects on humans, pharmacovigilance is a vital component of the healthcare system. The ability to monitor and analyze medications for quality as well as identify and halt any unfavorable drug side effects makes pharmacovigilance a crucial component of modern technology. Drug safety data collection and coding, as well as case management reporting and submission, comprise case processing, which is the first step in pharmacovigilance. The Pharmacovigilance Programme of India was established in response to these advancements. India participates in the Uppsala Monitoring Centre system but contributes very little to the database itself. The objective of this research is to conduct a comprehensive analysis of the pharmacovigilance program in India and provide a succinct, current evaluation of the organization, taking into account its background and possible issues. The development of “A Pharmacovigilance Programme of India” mobile application was emphasized by the National Coordination Centre PvPI to India as a means of enhancing public health and encouraging prompt reporting of adverse drug reactions. With more and more cutting-edge veterinary medications entering the market, India needs a veterinary pharmacovigilance system. One of the most significant current responsibilities is demonstrating to the world that thousands of years-old Ayurveda Siddha Unani systems are safe and grounded in science.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/adctra/10.2174/0126673371341986250228074620
2025-03-13
2025-09-28

  • From This Site

    /content/journals/adctra/10.2174/0126673371341986250228074620
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. SukeS.G. KostaP. NegiH. Role of pharmacovigilance in India: An overview.Online J. Public Health Inform.201572e22310.5210/ojphi.v7i2.559526392851
     [Google Scholar]
  2. AshwlayanV.D. NimeshS. Pharmacovigilance: An overview.Int. J. Pharmacovigil.2018311610.15226/2476‑2431/3/1/00124
     [Google Scholar]
  3. KumarS. BaldiA. Pharmacovigilance in India: Perspective and prospects.J. Drug Deliv. Ther.20133423710.22270/jddt.v3i4.619
     [Google Scholar]
  4. SinghS. PrakashJ. TomarR. Review on pharmacovigilance.World J. Pharm. Pharm. Sci.201546266275
     [Google Scholar]
  5. Dr NandhaR. Pharmacovigilance: Indian Perspective.Int. J. Drug Form. Res.201454315316
     [Google Scholar]
  6. TuranS. KaurP. Prospective study of pharmacovigilance in India-a review.Int J Pharm & Life Sci202011969836988
     [Google Scholar]
  7. Fulchand PawarS. Limbaji MusaleV. Pharmacovigilance: A review.Int. J. Adv. Res.20208123524310.21474/IJAR01/10289
     [Google Scholar]
  8. KumarA.Y. DivyaA. KumarR.K. A study on pharmacovigilance case processing.J innov Appl. Pharm. Sci.2022729599
     [Google Scholar]
  9. Pallavi PatilRK DuttaA A review on pharmacovigilance: Methods, recent developments, future perspectives, and software.J. Emer. Tech. Innov. Res.2021812308309
     [Google Scholar]
  10. JanjureM PainjaneS SnehalM Perspective on pharmacovigilance, recent development, challenges, and different software.J. Emer. Tech. Innov. Res.202296246248
     [Google Scholar]
  11. JadavB.H. ThulaK.C. MaheshwariD.G. Regulatory requirements of pharmacovigilance system and its comparison in India and USA.J. Glob. Trends Pharm. Sci.20156123512356
     [Google Scholar]
  12. FornasierG. FrancesconS. LeoneR. BaldoP. An historical overview over pharmacovigilance.Int. J. Clin. Pharm.201840474474710.1007/s11096‑018‑0657‑129948743
     [Google Scholar]
  13. KesharwaniV. FarooquiM.A. KushwahaN. SinghR.K. JaiswalP.K. An overview on pharmacovigilance: A key for drug safety and monitoring.J. Drug Deliv. Ther.20188513013510.22270/jddt.v8i5.1970
     [Google Scholar]
  14. RajgopalK.J. ShilpiK. SrivastavA.K. Pharmacovigilance: A review article.Int. J. Med. Sci.20164467
     [Google Scholar]
  15. KumarA.D. BashaA.S. ReddennaL. Pharmacovigilance programme of India.Inno Pharm201561189191
     [Google Scholar]
  16. JoseJ. RafeekR.N. Pharmacovigilance in India in comparison with USA and EU: Challenges and perspectives.Inno Reg Sci20184116
     [Google Scholar]
  17. SimhaH. MarisarlaS. MujeebuddinC.S. Pharmacovigilance system in India.Int. J. Pharm. Sci. Rev. Res.20206317380
     [Google Scholar]
  18. KhattriS. BalamuralidharaV. PramodK.T.M. ValluruR. VenkateshM.P. Pharmacovigilance regulations in India: A Step forward.Clin. Res. Regul. Aff.2012292414510.3109/10601333.2012.692688
     [Google Scholar]
  19. SinghN. SharmaG. KumarR. BhandariV. Pharmacovigilance in India and its impact in patient management.AMEI Curr. Trends Diagn. Treat.201711273310.5005/jp‑journals‑10055‑0006
     [Google Scholar]
  20. MathewsAM. Pharmacovigilance program of India- A study.Eur. J. Pharm. Med. Res.201741602607
     [Google Scholar]
  21. Sheetu Pharmacovigilance in India: Challenges and strategies.Int J Pharm Res App202162708715
     [Google Scholar]
  22. Pharmacovigilance Guidance document for Marketing Authorisation Holder for Pharmaceutical products.Indian Pharmacopoeia Commission201856
     [Google Scholar]
  23. Guidance of adverse drug reporting to the monitoring center for adverse drug reactions.Indian Pharmacopoeia Commission202089
     [Google Scholar]
  24. TomA. Pharmacovigilance and clinical safety: Comparison between India, US, and Eu-A review.Int J Res Dev Pharm L Sci20239226
     [Google Scholar]
  25. RaghuwanshiY. KhuleN. LigadeV. Veterinary pharmacovigilance: A review of systems in France, USA and India.Indian Vet. J.20231006711
     [Google Scholar]
  26. KumarR. KalaiselvanV. VermaR. KaurI. KumarP. SinghG.N. Veterinary pharmacovigilance in India: A need of hour.Indian J. Pharmacol.20174912310.4103/0253‑7613.20103528458414
     [Google Scholar]
  27. WoodwardK.N. Veterinary pharmacovigilance. Part 3. Adverse effects of veterinary medicinal products in animals and on the environment.J. Vet. Pharmacol. Ther.200528217118410.1111/j.1365‑2885.2005.00647.x15842306
     [Google Scholar]
  28. BaghelM.S. The national pharmacovigilance program for Ayurveda, Siddha and Unani drugs: Current status.Int. J. Ayurveda Res.20101419719810.4103/0974‑7788.7677921455443
     [Google Scholar]
  29. Suspected ADR.Available from: https://ipc.gov.in/images/ADR-Reporting-Form
  30. Medical Device adverse event reporting forms.Available from: https://cdsco.gov.in/opencms/resources/UploadCDSCOWeb/2018/UploadNewsFiles/MDAEform.pdf
  31. COVID-19 adverse event reporting form.Available from: https://www.ipc.gov.in/images/Suspected_ADR_Reporting_Form-converted_
  32. Adverse drug reaction reporting form for kala-azar treatmentAvailable from: https://www.ipc.gov.in/PvPI/adr/ADR%20reporting%20Form_Kala%20Azar_
  33. ADRPvPI.Available from: https://play.google.com/store/apps/details?id=com.vinfotech.suspectedadversedrugreaction
  34. PrakashJ. JoshiK. MalikD. MishraO. SachanA. KumarB. BhushanS. KalaiselvanV. SinghG. “ADR PvPI” Android mobile app: Report adverse drug reaction at any time anywhere in India.Indian J. Pharmacol.201951423624210.4103/ijp.IJP_595_1831571709
     [Google Scholar]
  35. Software Development Kit Tools Software development kit tools.2017Available from: https://developer.android.com/studio/release/sdk-tools
  36. MartinO. AdvinhaM.A. Mobile apps for quick adverse drug reaction report: A scoping review.Pharmaepido & Drug Safety2022321191
     [Google Scholar]
  37. ReleS.H. PateA. Pharmacovigilance programme of India: An overview.Pharm. Res.20235245
     [Google Scholar]
  38. TejaswiniA. NagabhushanamM.V. Current scenario of pharmacovigilance in India and its comparison with US and EU.World J. Pharm. Pharm. Sci.201989211
     [Google Scholar]
  39. JoseJ. RafeekN.R. Pharmacovigilance in India in comparison with the USA and European Union: Challenges and perspectives.Ther. Innov. Regul. Sci.201953678178610.1177/216847901881277530554527
     [Google Scholar]
  40. HansM GuptaKS Comparative evaluation of pharmacovigilance regulation of the US, UK, Canada, India, and the need for global harmonized practices.Pres. Clin. Res.201894171174
     [Google Scholar]
  41. Dave VivekS. Current trends in pharmacovigilance.J. Pharmacovigil.2012123435
     [Google Scholar]
  42. SinghM.N.K. KanaseH. Pharmacovigilance programme of India: The beginning, current status and recent progress.Adv. Pharmacoepidemiol. Drug Saf.20176413
     [Google Scholar]
  43. ParthasarthiG. HarugeriA. UndelaK. Pharmacovigilance research in India: A five-year literature review.Proc Ind Natn Sci Acad2018841225232
     [Google Scholar]
  44. NimeshS. ChaudharyA. SharmaA. NegiK.D. Pharmacovigilance programme of India: A review.Acta Scientific Pharm Sci2019391217
     [Google Scholar]
  45. KalaiselvanV. ThotaP. SinghG. Pharmacovigilance programme of India: Recent developments and future perspectives.Indian J. Pharmacol.201648662462810.4103/0253‑7613.19485528066097
     [Google Scholar]
  46. AnirudhprasadK. Current scenario of pharmacovigilance in India and its comparison with US and EU.Inno Pharma Technol201986302307
     [Google Scholar]
  47. Jaya KumarA. An overview of pharmacovigilance knowledge and reporting system among health care professionals.Int J Create Res Thoughts20221031620
     [Google Scholar]
  48. MaliS. PatilP. ShingeT. Pharmacovigilance.Int J Create Res Thoughts2023114320388
     [Google Scholar]
/content/journals/adctra/10.2174/0126673371341986250228074620
Loading
Pharmacovigilance Programme and Its Future Perspectives: Indian Scenario
Appl. Drug Resea., Clin. Trials and Regu. Affa. 11, e26673371341986 (2025); https://doi.org/10.2174/0126673371341986250228074620
/content/journals/adctra/10.2174/0126673371341986250228074620
/content/journals/adctra/10.2174/0126673371341986250228074620
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): android mobile app; cutting-edge veterinary; harmacodynamics; pharmacokinetics; Pharmacovigilance; thalidomide

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test